Drug Profile
Levocetirizine/pseudoephedrine - Hanmi Pharmaceutical
Alternative Names: Cossac L; HCP 0703; Pseudoephedrine/levocetirizineLatest Information Update: 08 Feb 2019
Price :
$50
*
At a glance
- Originator Hanmi Pharmaceutical
- Class Antiallergics; Decongestants; Nonsedating antihistamines; Piperazines; Propanolamines; Small molecules
- Mechanism of Action Alpha adrenergic receptor agonists; Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Allergic rhinitis
Most Recent Events
- 08 Feb 2019 Chemical structure information added
- 30 Apr 2013 Hanmi Pharmaceutical completes a phase III trial in Allergic rhinitis in South Korea (NCT01509209)
- 01 May 2011 Phase-III clinical trials in Allergic rhinitis in South Korea (PO)